James Hambro & Partners Johnson & Johnson Transaction History

James Hambro & Partners

  • $2.25 Billion
  • Q3 2024

A detailed history of James Hambro & Partners transactions in Johnson & Johnson stock. As of the latest transaction made, James Hambro & Partners holds 3,638 shares of JNJ stock, worth $525,581. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,638
Previous 3,778 3.71%
Holding current value
$525,581
Previous $552,000 6.7%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$145.48 - $167.38 $20,367 - $23,433
-140 Reduced 3.71%
3,638 $589,000
Q2 2024

Jul 16, 2024
SELL
$144.38 - $157.78 $45,624 - $49,858
-316 Reduced 7.72%
3,778 $552,000
Q1 2024

Apr 26, 2024
BUY
$155.22 - $162.74 $73,263 - $76,813
472 Added 13.03%
4,094 $647,000
Q4 2023

Jan 19, 2024
SELL
$145.6 - $158.88 $82,409 - $89,926
-566 Reduced 13.51%
3,622 $567,000
Q3 2023

Oct 24, 2023
BUY
$155.75 - $174.48 $7,943 - $8,898
51 Added 1.23%
4,188 $652,000
Q2 2023

Jul 20, 2023
BUY
$154.35 - $166.11 $46,305 - $49,833
300 Added 7.82%
4,137 $684,000
Q1 2023

Apr 21, 2023
BUY
$151.05 - $180.26 $66,613 - $79,494
441 Added 12.99%
3,837 $594,000
Q2 2022

Jul 22, 2022
SELL
$168.19 - $186.01 $35,319 - $39,062
-210 Reduced 5.82%
3,396 $602,000
Q1 2022

May 05, 2022
SELL
$158.14 - $179.59 $24,511 - $27,836
-155 Reduced 4.12%
3,606 $640,000
Q3 2021

Nov 05, 2021
BUY
$161.5 - $179.47 $25,032 - $27,817
155 Added 4.3%
3,761 $607,000
Q2 2021

Jul 20, 2021
SELL
$159.48 - $171.07 $757,370 - $812,411
-4,749 Reduced 56.84%
3,606 $594,000
Q1 2021

Apr 28, 2021
BUY
$153.07 - $170.48 $727,235 - $809,950
4,751 Added 131.83%
8,355 $1.37 Million
Q4 2020

Jan 14, 2021
SELL
$137.11 - $157.38 $1,645 - $1,888
-12 Reduced 0.33%
3,604 $567,000
Q3 2020

Oct 13, 2020
SELL
$140.38 - $153.83 $364,988 - $399,958
-2,600 Reduced 41.83%
3,616 $537,000
Q2 2020

Jul 13, 2020
BUY
$128.81 - $155.51 $437,954 - $528,734
3,400 Added 120.74%
6,216 $873,000
Q3 2019

Nov 04, 2019
SELL
$126.95 - $142.14 $43,797 - $49,038
-345 Reduced 10.91%
2,816 $364,000
Q1 2019

Apr 25, 2019
SELL
$125.72 - $139.79 $6,286 - $6,989
-50 Reduced 1.56%
3,161 $442,000
Q4 2018

Jan 17, 2019
SELL
$122.84 - $147.84 $25,182 - $30,307
-205 Reduced 6.0%
3,211 $414,000
Q2 2018

Jul 12, 2018
SELL
$119.4 - $131.76 $174,801 - $192,896
-1,464 Reduced 30.0%
3,416 $415,000
Q1 2018

Apr 30, 2018
BUY
$125.1 - $148.14 $25,020 - $29,627
200 Added 4.27%
4,880 $627,000
Q4 2017

Feb 13, 2018
BUY
$131.22 - $143.62 $614,109 - $672,141
4,680
4,680 $654,000

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track James Hambro & Partners Portfolio

Follow James Hambro & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

News

Stay updated on James Hambro & Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email